Amy Harper, M.D.
Assistant Professor
Clinical Interests: Muscular Dystrophy, Hypotonia, Developmental Delay, and Cerebral Palsy. Research Interests: Congenital Hypothyroidism
EDUCATION:
1998-1998 M.D., American University of the Caribbean, Montserrat, British Isles
1989-1992 B.A., University of Virginia, Charlottesville, Virginia
POST DOCTORAL TRAINING:
2005-2006 Neuromuscular Fellowship, Oregon Health & Science University
Department of Neurology/Neuromuscular
Portland, Oregon
2001-2005 Neurodevelopmental Disabilities Fellowship
Oregon Health & Science University
Child Developmental Rehabilitation Center
Portland, Oregon
1998-2001 Pediatric Residency
Brody School of Medicine, Department of Pediatrics
Greenville, North Carolina
PROFESSIONAL LICENSURE:
2001, 2007-Present North Carolina
2001-2006 Oregon
SPECIALTY CERTIFICATION:
2006 Board Eligible for American Board of Electrodiagnostic Medicine
2005 Board Eligible for Certification in Neurology with Special
Qualifications in Child Neurology and sub-specialization in
Neurodevelopmental Disabilities
2001 American Board of Pediatrics
Dr. Harper is originally from Richmond, Virginia. She attended the University of Virginia and graduated in 1992 with a degree in Biochemistry. After college, she worked 2 years as an environmental chemist, before pursing a medical career which landed her in Detroit, MI. She then completed a Pediatric Residency at East Carolina University in North Carolina. Following residency, she became a Neurodevelopmental Disabilities fellow at Oregon Health Sciences University in Portland, OR. Dr. Harper was the first fellow to complete this program nationwide. While at OHSU, she trained an additional year in neuromuscular diseases and EMG. She now continues her commitment to children with motor disabilities as a faculty member in Pediatric Neurology at Wake Forest University Baptist Medical Center.
Publications/Abstracts:
2004 Selva, K., Harper, A., Downs, A. Blasco, P., Lafranchi, S. Neurodevelopmental Outcomes in Congenital Hypothyroidism: Comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr 2005; 147: 775-80.